Cost effectiveness of interferon-gamma release assay for school-based tuberculosis screening.

Item

http://www.wikidata.org/entity/Q49177335

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Cost effectiveness of interfer ...... -based tuberculosis screening.

@en

Cost effectiveness of interfer ...... -based tuberculosis screening.

@nl

type

Item

label

Cost effectiveness of interfer ...... -based tuberculosis screening.

@en

Cost effectiveness of interfer ...... -based tuberculosis screening.

@nl

prefLabel

Cost effectiveness of interfer ...... -based tuberculosis screening.

@en

Cost effectiveness of interfer ...... -based tuberculosis screening.

@nl

P1476

Cost effectiveness of interfer ...... -based tuberculosis screening.

@en

P2093

Akiko Kowada

http://www.w3.org/2001/XMLSchema#string

P2860

School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.

Priorities for screening and treatment of latent tuberculosis infection in the United States

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.

Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis.

Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis.

The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis.

Cost-effectiveness analysis of interferon-γ release assays versus chest X-ray for annual tuberculosis screening of healthcare workers.

Cost-effectiveness of interferon-γ release assay versus chest X-ray for tuberculosis screening of employees.

Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-α antagonist therapy.

Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic.

P2888

bf03262207

P304

181-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03262207

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1032818499

http://www.w3.org/2001/XMLSchema#string

P698

22594558

http://www.w3.org/2001/XMLSchema#string